Skip Navigation


CIT can broadcast your seminar, conference or meeting live to a world-wide audience over the Internet as a real-time streaming video. The event can be recorded and made available for viewers to watch at their convenience as an on-demand video or a downloadable file. CIT can also broadcast NIH-only or HHS-only content.

Demystifying Medicine 2019 - Tuberculosis: The Great White Plague Keeps Coming Back

Loading video...

433 Views  
   
Air date: Tuesday, January 22, 2019, 4:00:00 PM
Time displayed is Eastern Time, Washington DC Local
Views: Total views: 433, (223 Live, 210 On-demand)
Category: Demystifying Medicine
Runtime: 01:36:14
Description: The Demystifying Medicine Lecture Series

Tuberculosis is one of the top 10 causes of death globally and the leading killer of people with HIV. Once thought to be under our control, the ancient plague has staged a global resurgence with worrisome strains of multidrug-resistant TB. In 2017, 10 million people fell ill with TB, and 1.6 million died from the disease, many as a result of these new strains, according to the World Health Organization.

For this next lecture in the Demystifying Medicine series, we bring you to the two frontlines of the TB battle. Ray Chen is a staff clinician in the NIAID Tuberculosis Research Section (TBRS). From 2004 to 2012, Chen was stationed in China administering NIAID's research and intervention projects for TB as well as HIV and influenza. China has an estimated one million new cases of TB every year. With help from NIAID, WHO, and China authorities, Chen witnessed a drop in the prevalence rate by 4.7 percent per year over the first decade of the 21st century. Nevertheless, the WHO estimates that there are 63,000 new multidrug-resistant TB infections annually in China, and much more work needs to be done.

Meanwhile, back at the NIH, NIAID TBRS Chief Clifton Barry commands a multidisciplinary group of research scientists comprising biologists, chemists, and clinical researchers in a race for therapeutics, diagnostic tools, and TB prevention strategies. Barry's lab has made remarkable strides in understanding the mechanism of action of anti-TB agents. His TBRS has the distinction of being the most highly cited research group in the world in the field of TB over the last 10 years.

For more information go to https://demystifyingmedicine.od.nih.gov
Debug: Show Debug
NLM Title: Demystifying medicine 2019. Tuberculosis : the great white plague keeps coming back / Ray Chen, Clifton Barry.
Author: Chen, Ray.
Barry, Clifton E.
National Institutes of Health (U.S.),
Publisher:
Abstract: (CIT): The Demystifying Medicine Lecture Series Tuberculosis is one of the top 10 causes of death globally and the leading killer of people with HIV. Once thought to be under our control, the ancient plague has staged a global resurgence with worrisome strains of multidrug-resistant TB. In 2017, 10 million people fell ill with TB, and 1.6 million died from the disease, many as a result of these new strains, according to the World Health Organization. For this next lecture in the Demystifying Medicine series, we bring you to the two frontlines of the TB battle. Ray Chen is a staff clinician in the NIAID Tuberculosis Research Section (TBRS). From 2004 to 2012, Chen was stationed in China administering NIAID's research and intervention projects for TB as well as HIV and influenza. China has an estimated one million new cases of TB every year. With help from NIAID, WHO, and China authorities, Chen witnessed a drop in the prevalence rate by 4.7 percent per year over the first decade of the 21st century. Nevertheless, the WHO estimates that there are 63,000 new multidrug-resistant TB infections annually in China, and much more work needs to be done. Meanwhile, back at the NIH, NIAID TBRS Chief Clifton Barry commands a multidisciplinary group of research scientists comprising biologists, chemists, and clinical researchers in a race for therapeutics, diagnostic tools, and TB prevention strategies. Barry's lab has made remarkable strides in understanding the mechanism of action of anti-TB agents. His TBRS has the distinction of being the most highly cited research group in the world in the field of TB over the last 10 years.
Subjects: Antitubercular Agents--therapeutic use
Clinical Trials as Topic
Drug Evaluation
Tuberculin Test
Tuberculosis, Multidrug-Resistant
Tuberculosis, Pulmonary--drug therapy
Tuberculosis, Pulmonary--transmission
Publication Types: Lecture
Webcasts
Download: To download this event, select one of the available bitrates:
[64k]  [150k]  [240k]  [440k]  [740k]  [1040k]  [1240k]  [1440k]  [1840k]    How to download a Videocast
Caption Text: Download Caption File
NLM Classification: WF 360
NLM ID: 101741367
CIT Live ID: 30257
Permanent link: https://videocast.nih.gov/launch.asp?27269